Thrombelastography rotational (ROTEM®) utility for monitoring patients with haemophilia and factor VIII inhibitors treated with rFVIIa (NOVOSEVEN®)

被引：0
|
作者：
Garcia-Rodriguez, M. [1 ]
Alvarez, M. [1 ]
Martin-Salces, M. [1 ]
Fernandez, I [1 ]
Butta, N. [1 ]
Rivas, I [1 ]
Munoz, I [1 ]
Jimenez-Yuste, V [1 ]
Hernandez-Navarro, F. [1 ]
机构：
[1] Hosp La Paz, Hematol, Madrid, Spain
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-TH-604
引用
收藏
页码：1135 / 1135
页数：1
相关论文
共 50 条
  • [11] Cost-utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea
    Lee, Hankil
    Cho, Hyeonseok
    Han, Jung Woo
    Kim, Ah-Young
    Park, Seonyoung
    Lee, Minjun
    Cho, Sunghwa
    Baik, Deborah
    Kang, Hye-Young
    HAEMOPHILIA, 2021, 27 (01) : E12 - E21
  • [12] Factor VIII assays in haemophilia A patients treated with ReFacto™
    Sukhu, K
    Harrison, P
    Keeling, D
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (02) : 379 - 380
  • [13] Factor VIII inhibitors in previously treated haemophilia a patients with a double virus-inactivated plasma derived factor VIII concentrate
    Peerlinck, K
    Arnout, J
    DiGiambattista, M
    Gilles, JG
    Laub, R
    Jacquemin, M
    SaintRemy, JMR
    Vermylen, J
    THROMBOSIS AND HAEMOSTASIS, 1997, 77 (01) : 80 - 86
  • [14] CLINICAL USE AND MONITORING OF ACTIVATED RECOMBINANT FACTOR FVII CONCENTRATE (RFVIIA) IN HEMOPHILIA A PATIENTS WITH FACTOR-VIII INHIBITORS
    MAKRIS, M
    KITCHEN, S
    RUSSELL, F
    PRESTON, FE
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 677 - 677
  • [15] A BUDGET IMPACT MODEL FOR NOVOSEVEN FOR THE MANAGEMENT OF BLEEDING EPISODES IN PATIENTS WITH HAEMOPHILIA A TREATED WITH INHIBITORS
    Kaskens, L.
    Martial, L.
    Montoro Ronsano, J. B.
    Ramirez de Arellano, A.
    Darba, J.
    VALUE IN HEALTH, 2013, 16 (07) : A379 - A379
  • [16] Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products
    Rota, Matteo
    Cortesi, Paolo A.
    Steinitz-Trost, Katharina N.
    Reininger, Armin J.
    Gringeri, Alessandro
    Mantovani, Lorenzo G.
    BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (08) : 627 - 637
  • [17] Recombinant factor VIIa (rFVIIa) by continuous infusion for pediatric haemophilia patients with inhibitors by
    Ogura, T.
    Horikoshi, Y.
    Kakazu, M.
    Abe, Y.
    Kudo, K.
    Watanabe, N.
    Takashima, Y.
    Miamya, J-, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 968 - 968
  • [18] Frequent but low titre factor VIII inhibitors in haemophilia A patients treated with high purity concentrates
    Zanon, E
    Zerbinati, P
    Girolami, B
    Bertomoro, A
    Girolami, A
    BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (03) : 117 - 120
  • [19] Development of factor VIII inhibitors in two patients with moderate haemophilia A
    Paschal, R. D.
    Meeks, S. L.
    Neff, A. T.
    HAEMOPHILIA, 2013, 19 (01) : E55 - E57
  • [20] Factor VIII inhibitors in haemophilia A patients after continuous infusion of factor VIII concentrates.
    von Auer, C
    Oldenburg, J
    Krause, M
    Miesbach, W
    Scharrer, I
    BLOOD, 2005, 106 (11) : 894A - 894A
12345